ONYX-one study

• Research type

  Research Study

• Full title

  A Randomized Controlled Trial with Resolute Onyx in One Month Dual Anti Platelet Therapy for High-Bleeding Risk Patients

• IRAS ID

  237721

• Contact name

  Azfar Zaman

• Contact email

  Azfar.Zaman@nuth.nhs.uk

• Sponsor organisation

  Medtronic

• Duration of Study in the UK

  1 years, 1 months, 1 days

• Research summary

  The purpose of this study is to evaluate the clinical safety and effectiveness of the Medtronic Resolute Onyx stent as compared to the BioFreedom stent in patients who suffer from coronary artery disease and need dual anti platelet therapy (DAPT)following the procedure.
  Both stents mentioned are approved for commercial use in all countries participating in this study

• REC name

  London - Dulwich Research Ethics Committee

• REC reference

  18/LO/0035

• Date of REC Opinion

  19 Mar 2018

• REC opinion

  Further Information Favourable Opinion